Skip to main content

Day: October 18, 2022

Claes Nycander elected as new Chair of the Board of Telia Lietuva

The Board of Telia Lietuva, AB (hereinafter – ‘Telia Lietuva‘ or ‚the Company‘) to substitute Douglas Lubbe, who resigned from position of the Chair of the Board and member of the Remuneration Committee as of 14 October 2022, has elected member of the Board, Claes Nycander, as new Chair of the Board of Telia Lietuva. Claes Nycander, as representative of the largest shareholder of Telia Lietuva, Telia Company AB, that holds 88.15 per cent of the Company’s shares and votes, to the Board of Telia Lietuva for the first time was elected on 29 April 2014 and afterwards four times re-elected for new terms of the Board. Claes Nycander is Vice President and Head of Chief Operating Officer Office & LED (Lithuania, Estonia, Denmark) Management at Common Products and Services (CPS) at Telia Company AB (Sweden). He is also member or Chair of...

Continue reading

trivago and AXS Partner to Encourage Sports and Live Entertainment Fans to “Make a Night of It!”

AXS Users Will Gain Access to Thousands of Accommodation Offers to Enhance Live Event Experiences Around the World DÜSSELDORF, GERMANY – 18 October 2022 – trivago, a leading global accommodation search platform, and AXS, a global leader in ticketing for live sports and entertainment events, today announced a global partnership combining a love for travel and live entertainment. The partnership, which was developed by AEG Global Partnerships, makes trivago the exclusive accommodation partner of AXS. It will also enable eventgoers to make the most of their night out by offering accessible, affordable stay booking options with event ticket purchases made via AXS. A first-of-its-kind deal for AXS, this represents a new partnership category for the ticketing platform. As part of the agreement, an interactive, trivago branded accommodation search...

Continue reading

Leggett & Platt Announces 3Q 2022 Earnings Call

Carthage, MO, Oct. 18, 2022 (GLOBE NEWSWIRE) — Leggett & Platt (NYSE:LEG), a diversified manufacturer of engineered products serving several major markets, will release third quarter earnings results on Monday, October 31, 2022 after the market closes, and hold its quarterly conference call to discuss third quarter results, annual guidance, market conditions and related matters on Tuesday, November 1, 2022 at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). This call will be webcast and can be accessed from the Investor Relations section of Leggett & Platt’s website at www.leggett.com. Dial in information: 201-689-8341, no passcode required. The earnings release and slides containing summary financial information will be posted to the Investor Relations section of our website on October 31 shortly after the market closes....

Continue reading

Caribou Biosciences Presents Case Report on Long-term Follow up of First Patient Dosed in Phase 1 ANTLER Trial at the Lymphoma, Leukemia, & Myeloma Congress 2022

Ongoing complete response at 15 months reported in first patient treated with CB-010 BERKELEY, Calif., Oct. 18, 2022 (GLOBE NEWSWIRE) — Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the presentation of a case report for long-term follow up on the first patient dosed in its ANTLER Phase 1 clinical trial for CB-010 in relapsed or refractory aggressive B cell non-Hodgkin lymphoma (r/r B-NHL). A recent evaluation showed the patient has maintained a complete response (CR) at 15 months after a single dose of CB-010. The case report will be presented at the Lymphoma, Leukemia, & Myeloma Congress being held in New York City, New York on October 18-22, 2022. The poster presentation provides long-term data for the first patient treated in the ANTLER...

Continue reading

Display Controller Market to Touch Valuation of $56.13 Billion by 2028 | NVIDIA and AMD are Enjoying King’s Position in Market

Global display controller market was valued at USD 29.12 billion in 2021, and the market size is estimated to reach USD 56.13 billion by 2028, at a CAGR of 9.68% over the forecast period (2022-2028). Westford, USA, Oct. 18, 2022 (GLOBE NEWSWIRE) — Display controller market has been witnessing high demand as graphics cards have become increasingly powerful and affordable. With more people using devices such as laptops, tablets and phones that have larger screens, the need for a good display controller has only increased. There are many different brands of display controllers available on the market. Some common features of a good display controller include HDCP support, ability to handle multiple resolutions and a wide selection of input and output ports. The demand for display controller market or graphics card has been growing...

Continue reading

Pharmaceuticals Market to Hit Sales of $14068.6 Billion by 2028 | Pharma Companies Invests Over $255 Billion in R&D Activities by 2026

Global pharmaceuticals market was valued at USD 12,459.7 billion in 2021, and it is expected to reach a value of USD 14,068.6 billion by 2028, at a CAGR of 1.75% over the forecast period (2022-2028). Westford, USA, Oct. 18, 2022 (GLOBE NEWSWIRE) — With ever-growing patient populations and advances in medical technology, the pharmaceuticals market is expected to grow at a moderate pace through 2028. However, growth is not uniform across all segments of the industry–in fact, new product launches and blockbuster drug approvals are more common in the blockbuster drugs category than anywhere else. The pharmaceuticals market is one that is experiencing significant growth. This growth is due to the increasing demand for pharmaceuticals from both individuals and businesses. Healthcare providers are increasingly looking for new and...

Continue reading

Hillstream’s New Anti-Cancer Mechanism Quatramer-based Ferroptosis Inducer, HSB-1216 Abstract Available for Viewing at EORTC-NCI-AACR Symposium

Abstract highlights data from HSB-1216 in acute myeloid leukemia (AML) growth BRIDGEWATER, N.J., Oct. 18, 2022 (GLOBE NEWSWIRE) — Hillstream BioPharma, Inc. (“Hillstream”), a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death for drug resistant and devastating cancers, today announced that an abstract highlighting the progress of the Quatramer-based Ferroptosis Inducer, HSB-1216, are available as a poster at the 34th EORTC- NCI – AACR Symposium (ENA 2022) in Barcelona taking place from October 26 -28, 2022. AML is characterized by the unbridled proliferation of myeloid progenitor cells. Unfortunately, despite recent advances in the treatment, the prognosis is poor for almost all older adults and half of patients under...

Continue reading

Conduent to Report Third-Quarter 2022 Financial Results on November 1, 2022

FLORHAM PARK, N.J., Oct. 18, 2022 (GLOBE NEWSWIRE) — Conduent Incorporated (Nasdaq: CNDT), a global technology-led business process solutions company, plans to report its third-quarter 2022 financial results on Tuesday, November 1, 2022, after market close. Management will present the results during a conference call and webcast at 5:00 p.m. ET. The call will be available by live audio cast along with the news release and online presentation slides at https://investor.conduent.com. The conference call will also be available by calling 877-407-4019 toll-free. If requested, the conference ID is 13732835. The international dial-in is 1-201-689-8337. The international conference ID is also 13732835. A recording of the conference call will be available by calling 1-877-660-6853 three hours after the conference call concludes. The access...

Continue reading

Microbot Medical Accomplishes the Next-Step in the Regulatory Process for the LIBERTY® Robotic System

HINGHAM, Mass., Oct. 18, 2022 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), announced that it has submitted the anticipated follow-up pre-submission package for the LIBERTY® Robotic System to ensure the Company remains fully aligned with the U.S. Food and Drug Administration (FDA) as it prepares for its Investigational Device Exemption (IDE) submission and first-in-human clinical trial with the system in 2023. “We have had a positive experience with the FDA to date, and we believe the continued dialogue and level of engagement is very constructive and encouraging as we prepare for our next regulatory steps in the USA for the LIBERTY Robotic System,” commented Harel Gadot, Chairman, CEO and President. “This planned submission is another critical step we needed to secure as we make our first-in-human preparations, and...

Continue reading

RioCan demonstrates leadership in ESG initiatives and recognition for ESG achievements

TORONTO, Oct. 18, 2022 (GLOBE NEWSWIRE) — RioCan Real Estate Investment Trust (“RioCan” or the “Trust”) (TSX: REI.UN) is pleased to provide an update on its environmental sustainability initiatives. The Trust is also proud to announce its 2022 GRESB Assessments results and BOMA awards, highlighting the strength of its ESG program. “Responsible stewardship is essential to protecting and maximizing long-term value. Whether they relate to existing assets or developments, our environmental sustainability initiatives are critical in transitioning to a low carbon economy,” said Jonathan Gitlin, President and Chief Executive Officer of RioCan. “RioCan is proud to lead the way in integrating ESG best practices in everything we do. We continue to make progress and it’s an honour to be recognized for our ESG achievements as exemplified by...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.